Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Insights and implications of sexual dimorphism in osteoporosis
Osteoporosis, a metabolic bone disease characterized by low bone mineral density and
deterioration of bone microarchitecture, has led to a high risk of fatal osteoporotic fractures …
deterioration of bone microarchitecture, has led to a high risk of fatal osteoporotic fractures …
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
K Maiese - Frontiers in immunology, 2023 - frontiersin.org
Life expectancy is increasing throughout the world and coincides with a rise in non-
communicable diseases (NCDs), especially for metabolic disease that includes diabetes …
communicable diseases (NCDs), especially for metabolic disease that includes diabetes …
Estrogen-immuno-neuromodulation disorders in menopausal depression
Y Zhang, X Tan, C Tang - Journal of neuroinflammation, 2024 - Springer
A significant decrease in estrogen levels puts menopausal women at high risk for major
depression, which remains difficult to cure despite its relatively clear etiology. With the …
depression, which remains difficult to cure despite its relatively clear etiology. With the …
Cellular metabolism: a fundamental component of degeneration in the nervous system
K Maiese - Biomolecules, 2023 - mdpi.com
It is estimated that, at minimum, 500 million individuals suffer from cellular metabolic
dysfunction, such as diabetes mellitus (DM), throughout the world. Even more concerning is …
dysfunction, such as diabetes mellitus (DM), throughout the world. Even more concerning is …
[HTML][HTML] Molecular mechanisms of the anti-inflammatory effects of epigallocatechin 3-gallate (EGCG) in LPS-activated BV-2 microglia cells
Brain Sciences | Free Full-Text | Molecular Mechanisms of the Anti-Inflammatory Effects of
Epigallocatechin 3-Gallate (EGCG) in LPS-Activated BV-2 Microglia Cells Next Article in …
Epigallocatechin 3-Gallate (EGCG) in LPS-Activated BV-2 Microglia Cells Next Article in …
The metabolic basis for nervous system dysfunction in alzheimer's disease, parkinson's disease, and huntington's disease
K Maiese - Current neurovascular research, 2023 - benthamdirect.com
Disorders of metabolism affect multiple systems throughout the body but may have the
greatest impact on both central and peripheral nervous systems. Currently available …
greatest impact on both central and peripheral nervous systems. Currently available …
[HTML][HTML] Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer's disease research
Alzheimer's disease (AD) is prevalent around the world, yet our understanding of the
disease is still very limited. Recent work suggests that the cornerstone of AD may include the …
disease is still very limited. Recent work suggests that the cornerstone of AD may include the …
[PDF][PDF] The role of estrogen therapy as a protective factor for Alzheimer's disease and dementia in postmenopausal women: a comprehensive review of the literature
N Ali, R Sohail, SR Jaffer, S Siddique, B Kaya… - Cureus, 2023 - cureus.com
The complete cessation of menstruation for 12 months with associated vasomotor symptoms
is termed menopause. Apart from playing a role in reproduction, estrogen significantly …
is termed menopause. Apart from playing a role in reproduction, estrogen significantly …
The role of NF-κB signaling pathway in reactive astrocytes among neurodegeneration after methamphetamine exposure by integrated bioinformatics
K Li, H Ling, X Wang, Q **e, C Gu, W Luo… - Progress in Neuro …, 2024 - Elsevier
Background Methamphetamine (METH) is a highly addictive stimulant that has become one
of the top five risk substances cause deaths from substance abuse. METH exposure …
of the top five risk substances cause deaths from substance abuse. METH exposure …
[HTML][HTML] AdipoRon's Impact on Alzheimer's Disease—A Systematic Review and Meta-Analysis
Alzheimer's disease (AD) remains a leading cause of cognitive decline and mortality
worldwide, characterized by neurodegeneration, synaptic deficiencies, and …
worldwide, characterized by neurodegeneration, synaptic deficiencies, and …